# Biotalys

荷兰 CTGB 建议 EU 范围批准 AGROBODY 蛋白生物杀菌剂 EVOCA 用于灰霉病与白粉病——蛋白生物防治的首个此类建议。

Source: https://cn.bioecon.ru/companies/biotalys/
Updated: 2026-07-07

- 国家: Belgium
- 代码: Euronext:BTLS

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 2026年5月完成的€1205万私募配售 | https://biotalys.com/media/news/biotalys-reports-full-year-2025-financial-results-and-business-highlights, https://www.biotalys.com/media/news/biotalys-reports-half-year-2026-financial-results-business-highlights, https://www.biotalys.com/system/files/media-documents/Full_Year_2025_investor_webcast_29_April_2026.pdf |
| 监管批准 | 美国EPA批准EVOCA(2025年12月);佛罗里达州注册(2026年4月) | https://biotalys.com/media/news/biotalys-receives-regulatory-approval-us-epa-evoca, https://biotalys.com/media/news/biotalys-reports-full-year-2025-financial-results-and-business-highlights, https://www.biotalys.com/media/news/biotalys-reports-half-year-2026-financial-results-business-highlights |
| 监管批准 | 荷兰CTGB建议在欧盟范围内批准EVOCA的活性成分（截至2025年2月） | https://biotalys.com/media/news/biotalys-reports-full-year-2025-financial-results-and-business-highlights, https://www.agribusinessglobal.com/biopesticides/biotalys-reports-progress-in-the-regulatory-review-of-evoca-in-both-u-s-and-eu/, https://www.biotalys.com/media/news/biotalys-provides-regulatory-review-update-evoca |
| 员工人数 | 截至2026年3月为62名员工 | https://www.marketscreener.com/quote/stock/BIOTALYS-NV-124363415/company/ |
| 营收 | 2025 年其他营业收入为 €304.3万（尚无商业产品收入） | https://biotalys.com/media/news/biotalys-reports-full-year-2025-financial-results-and-business-highlights, https://www.biotalys.com/system/files/media-documents/Full_Year_2025_investor_webcast_29_April_2026.pdf |

独立来源: agribusinessglobal.com, marketscreener.com

## 技术

- [微肽植物保护制剂](https://cn.bioecon.ru/technology/micropeptide-plant-protection/)